Table 4.
Gene product and functional properties | Reported functional studies in cancer | |
---|---|---|
LOH genes | ||
BRCA1 | Breast cancer 1, a nuclear phosphoprotein involved in maintaining DNA stability | Tumor suppressor function [43] |
MSH3 | MutS homolog 3, a subunit of MutS beta involved in DNA mismatch repair | Genetic instability caused by loss of MSH3 in cancers [44] |
PCGF2 | Polycomb group ring finger 2, involved in protein-protein interaction and transcription repression | Tumor suppressor function [45] |
PDGFRL | Platelet-derived growth factor receptor-like, a cell surface tyrosine kinase receptor | Mutation and gene loss correlated with breast cancer progression [46] and prostate cancer [47] |
BCR | Breakpoint cluster region | Putative tumor suppressor in meningiomas [48] |
ASE genes | ||
DSC3 | Desmocollin 3, a cell adhesion molecule in cadherin family | Epigenetic silencing of DSC3 is a common event in breast cancer [49] |
FGFR2 | Fibroblast growth factor receptor 2, a transmembrane tyrosine kinase | Hypermethylation of FGFR2 found in gastric cancer [50] |
MYEOV | Myeloma overexpressed, a putative transforming gene | Epigenetically inactivated in esophageal squamous cell carcinomas [51] |
TNFRSF10D | Tumor necrosis factor receptor superfamily, member 10 d, a member of TNF-receptor superfamily | Aberrant methylation in multiple tumor type and mapped to tumor suppressor region in prostate cancer [52,53] |
MGMT | O-6-methylguanine-DNA methyltransferase, a DNA repair gene | Methylation of MGMT in many types of cancers [41,42,54] and associated with poorer overall and disease-free survival [55] |
LOH, loss of heterozygosity; ASE, allele-specific expression.